Comprehensive assessment of chemotherapy-induced cognitive dysfunction in patients with breast cancer

Comprehensive assessment of chemotherapy-induced cognitive dysfunction in patients with breast cancer - Asssement of chemobrain

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000010330

Enrollment

100

Registered

2013-03-27

Start date

2013-03-27

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

patients with breast cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with breast cancer, who have received chemotherapy (including the aromatase inhibitor)

Exclusion criteria

Exclusion criteria: Patients with obvious neurological deficit before recieving chemotherapy

Design outcomes

Primary

Measure	Time frame
Cognitive function	—

Countries

Japan

Contacts

Public ContactMasahiko Sumitani

The University of Tokyo Hospital Department of Medical Engineering

Outcome results